✦ LIBER ✦

Complete Response after High-Dose Chemotherapy and Autologous Hemopoietic Stem Cell Transplatation in Metastatic Breast Cancer Results in Survival Benefit

✍ Scribed by Sobha Kurian; Muzzafar Qazilbash; Joseph Fay; S. Wolff; Roger Herzig; Gerry Hobbs; Pam Bunner; Robin Weisenborn; Melanie Aya-ay; Joseph Lynch; Solveig Ericson

Book ID: 109079436
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 180 KB
Volume: 12
Category: Article
ISSN: 1075-122X
DOI: 10.1111/j.1524-4741.2006.00341.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tandem and triple high-dose chemotherapy

Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer

✍ J. Huober; A. Schneeweiss; S. Hohaus; G. Wittmann; A. Meyer; S. Martin; H. Golds 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 97 KB

Comparison of Double and Triple High-Dos

Comparison of Double and Triple High-Dose Chemotherapy with Autologous Blood Stem Cell Transplantation in Patients with Metastatic Breast Cancer

✍ A. Schneeweiss; M. Hensel; R. Goerner; T. Khbeis; S. Hohaus; G. Egerer; E. Solom 📂 Article 📅 2001 🏛 AlphaMed Press 🌐 English ⚖ 70 KB

Use of Capecitabine as First-Line Therap

Use of Capecitabine as First-Line Therapy in Patients with Metastatic Breast Cancer Relapsing After High- Dose Chemotherapy and Autologous Stem Cell Support

✍ A. Bashey; S. Sundaram; S. Corringham; V. Jones; D. Lancaster; J. Silva-Gietzen; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 84 KB

HER2 overexpression as a prognostic fact

HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support

✍ Guarneri, V; Bengala, C; Orlandini, C; Gennari, A; Donati, S; Campani, D; Collec 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 124 KB

High-dose cisplatin, etoposide, and cycl

High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer

✍ George Somlo; James H. Doroshow; Stephen J. Forman; Lucille A. Leong; Kim A. Mar 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 901 KB

Expression of C-erbB-2/HER-2 in patients

Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support

✍ Bewick, M; Chadderton, T; Conlon, M; Lafrenie, R; Morris, D; Stewart, D; Glück, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB